For patient-related information about the ICT-107 cancer vaccine phase II program please:
- Access the ICT-107 FAQ (Frequently Asked Questions) click here.
- Send an email message to firstname.lastname@example.org, including your contact information and your specific questions.
- Call 818 264 2315 and leave a brief message, including your contact information and questions.
Someone knowledgeable about the ICT-107 clinical program will respond to your inquiry shortly.